Signaturefd, LLC Biomarin Pharmaceutical Inc Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Signaturefd, LLC holds 646 shares of BMRN stock, worth $43,042. This represents 0.0% of its overall portfolio holdings.

Number of Shares

646

Previous 882 26.76%

Holding current value

$43,042

Previous $72,000 37.5%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$69.02 - $93.84 $16,288 - $22,146	-236 Reduced 26.76%	646 $45,000
Q2 2024 Jul 29, 2024	SELL	$74.43 - $92.22 $41,606 - $51,550	-559 Reduced 38.79%	882 $72,000
Q1 2024 May 03, 2024	SELL	$83.81 - $99.0 $5,615 - $6,633	-67 Reduced 4.44%	1,441 $125,000
Q4 2023 Jan 31, 2024	BUY	$76.22 - $98.51 $17,149 - $22,164	225 Added 17.54%	1,508 $145,000
Q3 2023 Nov 03, 2023	BUY	$85.07 - $94.48 $16,588 - $18,423	195 Added 17.92%	1,283 $113,000
Q2 2023 Aug 01, 2023	BUY	$86.68 - $100.3 $9,101 - $10,531	105 Added 10.68%	1,088 $94,000
Q1 2023 Apr 28, 2023	SELL	$87.74 - $117.27 $701 - $938	-8 Reduced 0.81%	983 $95,000
Q4 2022 Jan 27, 2023	BUY	$80.93 - $108.63 $5,584 - $7,495	69 Added 7.48%	991 $102,000
Q3 2022 Nov 08, 2022	BUY	$82.16 - $96.94 $40,833 - $48,179	497 Added 116.94%	922 $78,000
Q2 2022 Aug 10, 2022	BUY	$71.48 - $86.85 $15,511 - $18,846	217 Added 104.33%	425 $35,000
Q1 2022 May 02, 2022	SELL	$74.28 - $92.69 $9,285 - $11,586	-125 Reduced 37.54%	208 $16,000
Q4 2021 Jan 25, 2022	BUY	$71.72 - $91.47 $1,004 - $1,280	14 Added 4.39%	333 $29,000
Q3 2021 Oct 28, 2021	BUY	$74.77 - $85.47 $7,252 - $8,290	97 Added 43.69%	319 $25,000
Q2 2021 Jul 26, 2021	BUY	$75.51 - $84.79 $3,095 - $3,476	41 Added 22.65%	222 $19,000
Q1 2021 Apr 30, 2021	SELL	$74.73 - $90.69 $9,490 - $11,517	-127 Reduced 41.23%	181 $14,000
Q4 2020 Feb 11, 2021	SELL	$72.61 - $90.2 $2,831 - $3,517	-39 Reduced 11.24%	308 $27,000
Q3 2020 Nov 03, 2020	SELL	$71.87 - $131.03 $8,336 - $15,199	-116 Reduced 25.05%	347 $26,000
Q2 2020 Jul 30, 2020	BUY	$79.55 - $124.22 $6,443 - $10,061	81 Added 21.2%	463 $57,000
Q1 2020 Apr 23, 2020	BUY	$71.37 - $96.85 $8,207 - $11,137	115 Added 43.07%	382 $32,000
Q4 2019 Feb 05, 2020	BUY	$64.27 - $86.37 $4,627 - $6,218	72 Added 36.92%	267 $23,000
Q3 2019 Oct 16, 2019	SELL	$67.4 - $85.11 $10,244 - $12,936	-152 Reduced 43.8%	195 $13,000
Q2 2019 Jul 31, 2019	SELL	$80.35 - $93.9 $8,838 - $10,329	-110 Reduced 24.07%	347 $30,000
Q1 2019 May 09, 2019	SELL	$84.2 - $98.62 $37,637 - $44,083	-447 Reduced 49.45%	457 $41,000
Q4 2018 Feb 13, 2019	BUY	$80.14 - $106.07 $8,574 - $11,349	107 Added 13.43%	904 $77,000
Q3 2018 Nov 15, 2018	BUY	$93.92 - $105.72 $469 - $528	5 Added 0.63%	797 $77,000
Q2 2018 Aug 14, 2018	BUY	$76.01 - $99.03 $54,499 - $71,004	717 Added 956.0%	792 $75,000
Q1 2018 May 08, 2018	BUY	$77.67 - $92.63 $5,825 - $6,947	75 New	75 $6,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account